ASH and HVO partner to launch hematology program in Peru

March 27, 2009

(WASHINGTON, March 27, 2009) - Following the success of a program established in Uganda last year, the American Society of Hematology (ASH) and Health Volunteers Overseas (HVO) have again partnered to launch a new hematology program together with the Peruvian Social Security Health System, Empresa De Seguros De Salud (EsSalud). The goal of this program is to improve the hematology training of clinicians, laboratory technicians, technologists, and students. This training will take place at hospitals located in Lima, Arequipa, and Cusco.

"We are enthusiastic to launch a new ASH/HVO hematology program in Peru," said Enrico M. Novelli, MD, director of the Peru program. "This is a great teaching and cultural exchange opportunity for ASH hematologist/oncologists, hematopathologists, and laboratory-based scientists with an expertise in areas such as bone marrow transplantation, coagulation disorders, lymphoproliferative disorders, or blood banking."

Volunteers will provide didactic and hands-on training in both the clinical and laboratory aspects of hematology to undergraduate medical and laboratory students, postgraduates, fellows, and staff. Volunteers will also assist in evaluating postgraduate fellow projects and aid in improving communication between the lab staff and clinicians.

Both pediatric or adult hematology/oncology clinicians and laboratory-based scientists are welcomed for assignments of one to four weeks. Volunteers must be board certified in hematology and/or blood banking. Individuals with a PhD must be certified in hematopathology or pathology with demonstrated experience in hematopathology. Applicants must be members of both ASH and HVO to be considered for this program, and volunteers from outside the United States are encouraged to apply. Although a working knowledge of Spanish is very helpful, it is not a requirement for this program. This site is not suitable for trainees.
-end-
To learn more about this program and how to volunteer, please visit ASH's HVO Program page.

Reporters may contact Patrick Irelan at 202-776-0544 or pirelan@hematology.org for more information.

The American Society of Hematology (www.hematology.org) is the world's largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology. In September 2008, ASH launched Blood: The Vital Connection (www.bloodthevitalconnection.org), a credible online resource addressing bleeding and clotting disorders, anemia, and cancer. It provides hematologist-approved information about these common blood conditions including risk factors, preventive measures, and treatment options.

A private, nonprofit membership organization, Health Volunteers Overseas was founded in 1986 to improve global health through education. HVO designs and implements clinical education programs in child health, primary care, trauma and rehabilitation, essential surgical care, oral health, hematology, infectious disease, nursing education, burn management, and wound care. In more than 25 resource-poor nations, volunteers train, mentor, and provide critical professional support to health-care providers who care for the neediest populations in the most difficult of circumstances. HVO's hematology training programs are sponsored by the American Society of Hematology. To learn more about volunteering with HVO, visit the Web site (www.hvousa.org) or contact the HVO Program Department at (202) 296-0928.

American Society of Hematology

Related Hematology Articles from Brightsurf:

Study finds gender disparities in hematology research success
Hematologists who complete a mentored training program experience greater levels of academic success than those who do not; however, a study published today in Blood Advances suggests a slight discrepancy in success levels between male and female hematologists.

Survey suggests mentorship in medical school is vital to future of hematology
A survey of US hematology-oncology fellows suggests medical school plays an important role in shaping their interest in pursuing careers in hematology, particularly when students are exposed to hematology and oncology as part of core clerkships in internal medicine and pediatrics.

JAK inhibitors associated with aggressive lymphoma
Austrian researchers have discovered that a small number of patients taking targeted drugs known as Janus kinase (JAK) inhibitors to treat myelofibrosis may develop aggressive lymphomas.

For young adults with blood cancer, pediatric centers may improve survival
Adolescents and young adults with acute leukemia have a survival advantage if they receive treatment at a pediatric cancer center versus an adult center, according to a new study.

Global hematology diagnostics market estimated to expand at a robust CAGR over 2021
Hematology includes various IVD technologies such as blood analysis, flow cytometry, immunodiagnostics, molecular diagnostics, hemostasis, histology, and cytology.

Late-breaking hematology abstracts signal new, near-term therapeutic options for patients
In four clinical trials being presented today during the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta, researchers report promising results suggesting patients with blood disorders and several types of cancer will soon have significantly expanded options for treatment.

American Society of Hematology announces top trainee abstracts of 2016 ASH Annual Meeting
The American Society of Hematology (ASH) is pleased to recognize the following trainees with the highest-scoring abstracts in the categories of undergraduate student, medical student, graduate student, resident physician, and postdoctoral fellow at the 58th ASH Annual Meeting Dec.

ASH to expand family of blood journals with launch of new cutting-edge publication
The American Society of Hematology (ASH) will launch an open-access journal to complement Blood, its flagship publication and the most-cited journal in hematology.

Study finds common genetic variants that double risk for blood clots in African Americans
New research published online today in Blood the Journal of the American Society of Hematology, identifies common genetic variants predominantly found in African Americans that double their risk for blood clots.

Mount Sinai researchers present results at American Society of Hematology Meeting
Icahn School of Medicine at Mount Sinai researchers will present several landmark studies at the 2015 American Society of Hematology meeting Dec.

Read More: Hematology News and Hematology Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.